<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <atom:link href="https://feeds.megaphone.fm/lifemd" rel="self" type="application/rss+xml"/>
    <title>LifeMD Podcast</title>
    <language>en</language>
    <copyright></copyright>
    <description>More than 40% of adults in the US struggle with obesity, a chronic disease that's linked to more than 200 comorbidities. Fortunately, breakthrough medications called GLP-1s are helping millions of people lose weight and improve their health, and the leading telehealth company, Life MD, is leading the charge.&amp;nbsp;
It's lauded weight management program combines these groundbreaking medications with personalized treatment plans and ongoing clinical support. Today, we are joined by Dr. Banita Sehgal, a prescribing physician for Life MD and an expert in sustainable weight management.</description>
    <image>
      <url>https://megaphone.imgix.net/podcasts/a002f07e-be48-11ef-ab5e-4f848bd0cc4c/image/162ac352b093a0b7b70f94beda7e9352.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress</url>
      <title>LifeMD Podcast</title>
    </image>
    <itunes:explicit>no</itunes:explicit>
    <itunes:type>episodic</itunes:type>
    <itunes:subtitle>LifeMD Podcast</itunes:subtitle>
    <itunes:author>Hearst StoryStudio</itunes:author>
    <itunes:summary>More than 40% of adults in the US struggle with obesity, a chronic disease that's linked to more than 200 comorbidities. Fortunately, breakthrough medications called GLP-1s are helping millions of people lose weight and improve their health, and the leading telehealth company, Life MD, is leading the charge.&amp;nbsp;
It's lauded weight management program combines these groundbreaking medications with personalized treatment plans and ongoing clinical support. Today, we are joined by Dr. Banita Sehgal, a prescribing physician for Life MD and an expert in sustainable weight management.</itunes:summary>
    <content:encoded>
      <![CDATA[<p>More than 40% of adults in the US struggle with obesity, a chronic disease that's linked to more than 200 comorbidities. Fortunately, breakthrough medications called GLP-1s are helping millions of people lose weight and improve their health, and the leading telehealth company, Life MD, is leading the charge.&nbsp;</p><p>It's lauded weight management program combines these groundbreaking medications with personalized treatment plans and ongoing clinical support. Today, we are joined by Dr. Banita Sehgal, a prescribing physician for Life MD and an expert in sustainable weight management.</p>]]>
    </content:encoded>
    <itunes:owner>
      <itunes:name>Hearst StoryStudio</itunes:name>
      <itunes:email>monti.rossetti@hearststorystudio.com</itunes:email>
    </itunes:owner>
    <itunes:image href="https://megaphone.imgix.net/podcasts/a002f07e-be48-11ef-ab5e-4f848bd0cc4c/image/162ac352b093a0b7b70f94beda7e9352.png?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
    <itunes:category text="Health &amp; Fitness">
    </itunes:category>
    <item>
      <title>LifeMD Podcast</title>
      <description></description>
      <pubDate>Thu, 19 Dec 2024 20:35:25 -0000</pubDate>
      <itunes:title>LifeMD Podcast</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Hearst StoryStudio</itunes:author>
      <itunes:subtitle>LifeMD Podcast</itunes:subtitle>
      <itunes:summary></itunes:summary>
      <content:encoded>
        <![CDATA[]]>
      </content:encoded>
      <itunes:duration>573</itunes:duration>
      <guid isPermaLink="false"><![CDATA[bf5c7b98-be48-11ef-a562-032f444d42bf]]></guid>
      <enclosure url="https://traffic.megaphone.fm/HSS1210756842.mp3?updated=1734640814" length="0" type="audio/mpeg"/>
    </item>
  </channel>
</rss>
